AUPH
Aurinia Pharmaceuticals Inc.
NASDAQ · CAHealthcareBiotechnology
$15.25-4.45%
Price as of Jul 20, 2026
AUPH profitability
Aurinia Pharmaceuticals Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 89.7%
- EBITDA margin
- 54.2%
- EBIT margin
- 41.7%
- Net margin
- 100.0%
- Free cash flow margin
- 55.5%
Returns
- Return on equity
- 52.5%
- Return on assets
- 41.2%
- Return on invested capital
- 19.6%
- Asset turnover
- 0.40x
Cash efficiency
- Cash from operations
- $165.8M
- Cash per share
- $2.95
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.